AN2 Therapeutics, Inc. (ANTX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.76
+3.44%
Mkt Cap $123.31M
EPS — Estimate vs Actual
Mkt Cap
$123.31M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.10
NASDAQ·Healthcare·Biotechnology
$3.76
+3.44%
Mkt Cap $123.31M
Mkt Cap
$123.31M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.10